Advertisement

Neuropalliative Care: An Introduction

  • Claire J. CreutzfeldtEmail author
  • Benzi M. Kluger
  • Robert G. Holloway
Chapter

Abstract

Fifty years ago, Dame Cicely Saunders started the hospice movement emphasizing that there is so much more to be done, when patients with cancer and other terminal illnesses were being told there was nothing more. By easing symptom burden, by giving dying patients the opportunity to say ‘thank you’ and ‘sorry’ to family and friends, by improving the quality rather than the quantity of life, and by not ‘giving up’ on dying patients, the hospice movement revolutionized end-of-life care. Palliative care is a philosophy of care for patients with serious illness and their families that was born with the hospice movement, with the difference that palliative care is not limited to patients nearing the end of life, but is appropriate at any age, stage of illness, or prognosis. Palliative care is now revolutionizing medical care by placing a central focus on helping patients and their families lead a good life across the continuum of the disease, from the time of diagnosis until death. Focused on improving communication about goals of care and maximizing comfort and quality of life, palliative care is both a medical subspecialty as well as an approach to medical care that can and should be incorporated into the care of all patients with serious illness.

Keywords

Neuropalliative care Palliative care approach Illness trajectories Serious illness conversation 

References

  1. 1.
    World Health Organization W. Neurological Disorders: Public Health Challenges. 2006. http://www.who.int/mental_health/neurology/neurodiso/en/. Accessed last accessed 01/09/2018.
  2. 2.
    Feigin VL, Forouzanfar MH, Krishnamurthi R, et al. Global and regional burden of stroke during 1990–2010: findings from the Global Burden of Disease Study 2010. Lancet. 2014;383(9913):245–54.CrossRefGoogle Scholar
  3. 3.
    Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010;363(8):733–42.CrossRefGoogle Scholar
  4. 4.
    Zimmermann C, Swami N, Krzyzanowska M, et al. Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014;383(9930):1721–30.CrossRefGoogle Scholar
  5. 5.
    Bakitas M, Lyons KD, Hegel MT, et al. Effects of a palliative care intervention on clinical outcomes in patients with advanced cancer: the Project ENABLE II randomized controlled trial. JAMA. 2009;302(7):741–9.CrossRefGoogle Scholar
  6. 6.
    Yoong J, Park ER, Greer JA, et al. Early palliative care in advanced lung cancer: a qualitative study. JAMA Intern Med. 2013;173(4):283–90.CrossRefGoogle Scholar
  7. 7.
    Tran LN, Back AL, Creutzfeldt CJ. Palliative care consultations in the neuro-ICU: a qualitative study. Neurocrit Care. 2016;25(2):266–72.CrossRefGoogle Scholar
  8. 8.
    Quill TE, Abernethy AP. Generalist plus specialist palliative care – creating a more sustainable model. N Engl J Med. 2013;368(13):1173–5.CrossRefGoogle Scholar
  9. 9.
    Institute of Medicine CoQoHCiA. Dying in America: improving quality and honoring individual preferences near the end of life. 1st ed. Washington, DC: National Academies Press; 2015.Google Scholar
  10. 10.
    Wingerchuk DM, Carter JL. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clin Proc. 2014;89(2):225–40.CrossRefGoogle Scholar
  11. 11.
    Kluger BM, Klepitskaya O, Okun MS. Surgical treatment of movement disorders. Neurol Clin. 2009;27(3):633–77. vCrossRefGoogle Scholar
  12. 12.
    Koton S, Schneider AL, Rosamond WD, et al. Stroke incidence and mortality trends in US communities, 1987 to 2011. JAMA. 2014;312(3):259–68.CrossRefGoogle Scholar
  13. 13.
    Fischer U, Kaesmacher J, Mendes Pereira V, et al. Direct mechanical thrombectomy versus combined intravenous and mechanical thrombectomy in large-artery anterior circulation stroke: a topical review. Stroke. 2017;48(10):2912–8.CrossRefGoogle Scholar
  14. 14.
    Nelson CE, Robinson-Hamm JN, Gersbach CA. Genome engineering: a new approach to gene therapy for neuromuscular disorders. Nat Rev Neurol. 2017;13(11):647–61.CrossRefGoogle Scholar
  15. 15.
    Mendell JR, Al-Zaidy S, Shell R, et al. Single-dose gene-replacement therapy for spinal muscular atrophy. N Engl J Med. 2017;377(18):1713–22.CrossRefGoogle Scholar
  16. 16.
    Loftus AM, Wade C, McCarron MO. Primary care perceptions of neurology and neurology services. Postgrad Med J. 2016;92(1088):318–21.CrossRefGoogle Scholar
  17. 17.
    Manu E, Marks A, Berkman CS, Mullan P, Montagnini M, Vitale CA. Self-perceived competence among medical residents in skills needed to care for patients with advanced dementia versus metastatic cancer. J Cancer Educ. 2012;27(3):515–20.CrossRefGoogle Scholar
  18. 18.
    Creutzfeldt CJ, Longstreth WT, Holloway RG. Predicting decline and survival in severe acute brain injury: the fourth trajectory. BMJ. 2015;351:h3904.CrossRefGoogle Scholar
  19. 19.
    Koekkoek JA, Chang S, Taphoorn MJ. Palliative care at the end-of-life in glioma patients. Handb Clin Neurol. 2016;134:315–26.CrossRefGoogle Scholar
  20. 20.
    Rachael E.C. Schutz, Heather L. Coats, Ruth A. Engelberg, J. Randall Curtis, Claire J. Creutzfeldt, (2017) Is There Hope? Is She There? How Families and Clinicians Experience Severe Acute Brain Injury. Journal of Palliative Medicine 20 (2):170–176CrossRefGoogle Scholar
  21. 21.
    Clarke DM, McLeod JE, Smith GC, Trauer T, Kissane DW. A comparison of psychosocial and physical functioning in patients with motor neurone disease and metastatic cancer. J Palliat Care. 2005;21(3):173–9.PubMedGoogle Scholar
  22. 22.
    Boersma I, Miyasaki J, Kutner J, Kluger B. Palliative care and neurology: time for a paradigm shift. Neurology. 2014;83(6):561–7.CrossRefGoogle Scholar
  23. 23.
    Gilbert DT, Wilson TD. Miswanting: some problems in the forecasting of future affective states. New York: Cambridge University Press; 2000.Google Scholar
  24. 24.
    Creutzfeldt CJ, Holloway RG. Treatment decisions after severe stroke: uncertainty and biases. Stroke. 2012;43(12):3405–8.CrossRefGoogle Scholar
  25. 25.
    Achterberg WP, Pieper MJ, van Dalen-Kok AH, et al. Pain management in patients with dementia. Clin Interv Aging. 2013;8:1471–82.CrossRefGoogle Scholar
  26. 26.
    Kehayia E, Korner-Bitensky N, Singer F, et al. Differences in pain medication use in stroke patients with aphasia and without aphasia. Stroke. 1997;28(10):1867–70.CrossRefGoogle Scholar
  27. 27.
    Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson’s disease. Parkinsonism Relat Disord. 2002;8(3):193–7.CrossRefGoogle Scholar
  28. 28.
    Tuck KK, Brod L, Nutt J, Fromme EK. Preferences of patients with Parkinson’s disease for communication about advanced care planning. Am J Hosp Palliat Care. 2015;32(1):68–77.CrossRefGoogle Scholar
  29. 29.
    Goodlin SJ. Palliative care in congestive heart failure. J Am Coll Cardiol. 2009;54(5):386–96.CrossRefGoogle Scholar
  30. 30.
    Ha JF, Longnecker N. Doctor-patient communication: a review. Ochsner J. 2010;10(1):38–43.PubMedPubMedCentralGoogle Scholar
  31. 31.
    O’Brien MR, Whitehead B, Jack BA, Mitchell JD. From symptom onset to a diagnosis of amyotrophic lateral sclerosis/motor neuron disease (ALS/MND): experiences of people with ALS/MND and family carers – a qualitative study. Amyotroph Lateral Scler. 2011;12(2):97–104.CrossRefGoogle Scholar
  32. 32.
    Azoulay E, Pochard F, Kentish-Barnes N, et al. Risk of post-traumatic stress symptoms in family members of intensive care unit patients. Am J Respir Crit Care Med. 2005;171(9):987–94.CrossRefGoogle Scholar
  33. 33.
    Robinson MT, Vickrey BG, Holloway RG, et al. The lack of documentation of preferences in a cohort of adults who died after ischemic stroke. Neurology. 2016;86(22):2056–62.CrossRefGoogle Scholar
  34. 34.
    Sleeman KE, Ho YK, Verne J, et al. Place of death, and its relation with underlying cause of death, in Parkinson’s disease, motor neurone disease, and multiple sclerosis: a population-based study. Palliat Med. 2013;27(9):840–6.CrossRefGoogle Scholar
  35. 35.
    Teno JM, Mitchell SL, Gozalo PL, et al. Hospital characteristics associated with feeding tube placement in nursing home residents with advanced cognitive impairment. JAMA. 2010;303(6):544–50.CrossRefGoogle Scholar
  36. 36.
    George BP, Kelly AG, Schneider EB, Holloway RG. Current practices in feeding tube placement for US acute ischemic stroke inpatients. Neurology. 2014;83(10):874–82.CrossRefGoogle Scholar
  37. 37.
    Singh T, Peters SR, Tirschwell DL, Creutzfeldt CJ. Palliative care for hospitalized patients with stroke: results from the 2010 to 2012 National Inpatient Sample. Stroke. 2017;48(9):2534–40.CrossRefGoogle Scholar
  38. 38.
    Prabhakaran S, Cox M, Lytle B, et al. Early transition to comfort measures only in acute stroke patients: analysis from the Get With The Guidelines-Stroke registry. Neurol Clin Pract. 2017;7(3):194–204.CrossRefGoogle Scholar
  39. 39.
    Mack JW, Cronin A, Taback N, et al. End-of-life care discussions among patients with advanced cancer: a cohort study. Ann Intern Med. 2012;156(3):204–10.CrossRefGoogle Scholar
  40. 40.
    Curtis JR, Patrick DL, Caldwell ES, Collier AC. Why don’t patients and physicians talk about end-of-life care? Barriers to communication for patients with acquired immunodeficiency syndrome and their primary care clinicians. Arch Intern Med. 2000;160(11):1690–6.CrossRefGoogle Scholar
  41. 41.
    Anderson WG, Pantilat SZ, Meltzer D, et al. Code status discussions at hospital admission are not associated with patient and surrogate satisfaction with hospital care: results from the multicenter hospitalist study. Am J Hosp Palliat Care. 2011;28(2):102–8.CrossRefGoogle Scholar
  42. 42.
    Detering KM, Hancock AD, Reade MC, Silvester W. The impact of advance care planning on end of life care in elderly patients: randomised controlled trial. BMJ. 2010;340:c1345.CrossRefGoogle Scholar
  43. 43.
    Wright AA, Mack JW, Kritek PA, et al. Influence of patients’ preferences and treatment site on cancer patients’ end-of-life care. Cancer. 2010;116(19):4656–63.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Claire J. Creutzfeldt
    • 1
    Email author
  • Benzi M. Kluger
    • 2
  • Robert G. Holloway
    • 3
  1. 1.Department of NeurologyUniversity of Washington Harborview Medical CenterSeattleUSA
  2. 2.Department of NeurologyUniversity of Colorado Anschutz Medical CampusAuroraUSA
  3. 3.Department of NeurologyUniversity of Rochester Medical CenterRochesterUSA

Personalised recommendations